Capricor Announces Publication Highlighting New Advances

Capricor Announces Publication Highlighting New Advances for its ...

D., Capricor's chief executive officer. “This data shows that exosomes may be used effectively to deliver viral proteins for immunization and ...

StealthX™ Exosome Platform Shows Multivalent Vaccine Induces Long-Lasting Immunity to Multiple SARS-CoV-2 Proteins- SAN DIEGO, Jan.

Capricor Therapeutics to Present Exosome Platform Updates at ...

Abstract Highlights New Preclinical Data on Exosome-Based Delivery ... advance this technology.” The abstract will be made available on ...

Capricor Announces Publication Highlighting New Advances for its ...

20 likes, 0 comments - capricortherapeutics pada January 12, 2023: "Capricor Announces Publication Highlighting New Advances for its Engineered Exosome ...

Capricor Announces Peer-Reviewed Publication Demonstrating the ...

-Capricor's StealthX™ Exosome Platform Designed to Support the Advancement of Next Generation Vaccines and Therapeutics- ... “Exosomes offer a new ...

Press Releases :: Capricor Therapeutics, Inc. (CAPR)

... Recent Updates on CAP-1002 Program. Jan 12, 2023 9:26 am EST. Capricor Announces Publication Highlighting New Advances for its Engineered Exosome Platform. Nov ...

Capricor Announces Publication Highlighting New Advances for its ...

Capricor Announces Publication Highlighting New Advances for its Engineered Exosome Platform. 2 years ago$CAPRHealth CareGlobeNewswire PR. We notified Quantis ...

Capricor Therapeutics announces publication engineered exosome ...

Capricor Therapeutics announced the publication of a preclinical study highlighting new advances for its engineered exosome program.

Capricor Therapeutics Inc Announces Publication Highlighting New ...

CAPRICOR ANNOUNCES PUBLICATION HIGHLIGHTING NEW ADVANCES FOR ITS ENGINEERED EXOSOME PLATFORM. Login or create a forever free account to read this news. Let's go.

Capricor Therapeutics Announces New Advances in Exosome ...

Capricor Therapeutics Announces New Advances in Exosome-Mediated mRNA Delivery Platform · Key takeaways from this pre-clinical study include:.

Capricor's StealthX Platform Shows Promise in DMD Treatment ...

Capricor Therapeutics (NASDAQ: CAPR) announced the presentation of new preclinical data on their StealthX™ exosome platform at the 2024 ...

Capricor Therapeutics to Present Exosome Platform Updates at the ...

Capricor is also harnessing the power of our exosome technology, using our proprietary StealthX™ platform in preclinical development focused on ...

Capricor Therapeutics Announces Positive Long-Term Data

Capricor Therapeutics Announces Positive Long-Term Data from HOPE-2 OLE Study in Duchenne Muscular Dystrophy at 2024 World Muscle Society ...

Capricor Therapeutics Announces Publication Demonstrating ...

Publication supports Capricor's exosome platform advancements. Demonstrated ability to enhance potency of therapeutic cells. Potential for ...

Capricor Therapeutics Announces Collaboration with the National ...

“We are extremely pleased with the external support from the NIH, which highlights the clinical potential of our StealthX™ exosome platform ...

Capricor Therapeutics, Inc. (CAPR) Latest Press Releases ...

Capricor Therapeutics, Inc. (CAPR) · Capricor Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update · Capricor Therapeutics to ...

Capricor Therapeutics Announces Late-Breaking Presentations at ...

This early data suggests that Capricor's StealthX™ technology holds promise for enhancing the delivery of ASO therapies to muscle tissues, ...

Capricor Therapeutics Reports Third Quarter 2024 Financial Results ...

D., Capricor's chief executive officer. “In addition, we continue to advance our proprietary StealthX™ platform technology as part of our long- ...

Capricor Therapeutics to Present Exosome Platform Updates at ...

... announced that an abstract featuring new preclinical data highlighting the therapeutic potential of its StealthX™ exosome platform ...

Capricor Therapeutics Announces Positive Skeletal Muscle and ...

CAP-1002 is the company's novel cell therapy. Data from the HOPE-2 OLE study demonstrated improvements in multiple cardiac measures, including ...